A pa­tient with an au­toim­mune dis­ease has died af­ter re­ceiv­ing an ex­per­i­men­tal ge­net­ic med­i­cine from a biotech start­up in Chi­na, End­points News has learned. The Shang­hai-based com­pa­ny, Ri­boX Ther­a­peu­tics, re­cent­ly re­ceived a green light from the FDA to be­gin a clin­i­cal tri­al of the treat­ment in the US, which the com­pa­ny an­nounced on Aug...